(Q40234950)

18 September 2017

Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT. (English)

1 reference

18 September 2017

0 references

1 reference

1 reference

Daniel R Scoles

1

1 reference

18 September 2017

James Pavelka

2

1 reference

18 September 2017

Ilana Cass

3

1 reference

18 September 2017

Hang Tran

4

1 reference

18 September 2017

Rae L Baldwin

5

1 reference

18 September 2017

Klara Armstrong

6

1 reference

18 September 2017

Beth Y Karlan

7

1 reference

18 September 2017

language of work or name

English

0 references

publication date

7 September 2006

1 reference

18 September 2017

1 reference

18 September 2017

104

1 reference

18 September 2017

120-128

1 reference

18 September 2017

1

1 reference

describes a project that uses

18 September 2017

CSOC 882

0 references

cites work

Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Relevance of breast cancer cell lines as models for breast tumours: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

A rapid banding technique for human chromosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Characterization of a human ovarian teratocarcinoma-derived cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Characterization of a human ovarian carcinoma cell line: UCI 101.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

eIF4E as a marker for cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Independence of the prognostic value of tumor suppressor protein expression in ovarian adenocarcinomas: A multivariate analysis of expression of p53, retinoblastoma, and related proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

A human ovarian carcinoma murine xenograft model useful for preclinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa").

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

An evaluation of the ability of pifithrin-alpha and -beta to inhibit p53 function in two wild-type p53 human tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Immunologic characterization of tumor markers in human ovarian cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Taxol suppresses dynamics of individual microtubules in living human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Chemotherapy-induced apoptosis in epithelial ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Heterotransplantation of Human Malignant Tumors in “Nude” Thymusless Mice. II. Malignant Tumors Induced by Injection of Cell Cultures Derived From Human Solid Tumors 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Epidermal growth factor stimulates the cell growth of the PA-1 teratocarcinoma cell line in an autocrine/paracrine fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Applying the principles of stem-cell biology to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

Tumour stem cells and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2006.07.023

1 reference

release_hhybzgmkkfh7lf66carxl7dhzy

18 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hhybzgmkkfh7lf66carxl7dhzy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference